Literature DB >> 18769234

Inflammation and immunity in diabetic vascular complications.

Jan Nilsson1, Eva Bengtsson, Gunilla Nordin Fredrikson, Harry Björkbacka.   

Abstract

PURPOSE OF REVIEW: Diabetes is associated with an increased risk for cardiovascular disease. The purpose of this review is to discuss possible mechanisms through which diabetes can contribute to a more aggressive atherosclerotic disease process with a particular focus on the role of innate and adaptive immunity. RECENT
FINDINGS: The observation that adaptive immune responses to oxidized LDL modulate atherosclerotic plaque development has led to development of pilot vaccines that inhibit atherosclerosis in experimental animals. Recent studies have shown that similar immune responses operate against self-antigens modified by glycation in diabetes. Diabetes has also been shown to activate proinflammatory innate immune receptors and intracellular oxidative stress.
SUMMARY: There are many similarities between the autoimmune responses against oxidized LDL and proteins modified by glycation. The role of autoimmune responses against modified self-antigens in the development of diabetic vascular complications represents a relatively unexplored concept that potentially could provide significant new mechanistic insight into the underlying disease process and identify novel targets for intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18769234     DOI: 10.1097/MOL.0b013e32830f47cd

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  16 in total

1.  Impaired biomechanical properties of diabetic skin implications in pathogenesis of diabetic wound complications.

Authors:  Dustin M Bermudez; Benjamin J Herdrich; Junwang Xu; Robert Lind; David P Beason; Marc E Mitchell; Louis J Soslowsky; Kenneth W Liechty
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  The role of endothelial cell adhesion molecules P-selectin, E-selectin and intercellular adhesion molecule-1 in leucocyte recruitment induced by exogenous methylglyoxal.

Authors:  Yang Su; Xi Lei; Lingyun Wu; Lixin Liu
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

3.  Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.

Authors:  Ainhoa Oguiza; Carlota Recio; Iolanda Lazaro; Beñat Mallavia; Julia Blanco; Jesus Egido; Carmen Gomez-Guerrero
Journal:  Diabetologia       Date:  2015-04-28       Impact factor: 10.122

4.  ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients.

Authors:  Barnabas Gellen; Nathalie Thorin-Trescases; Philippe Sosner; Elise Gand; Pierre-Jean Saulnier; Stéphanie Ragot; Mathilde Fraty; Stéphanie Laugier; Grégory Ducrocq; David Montaigne; Pierre Llaty; Vincent Rigalleau; Philippe Zaoui; Jean-Michel Halimi; Ronan Roussel; Eric Thorin; Samy Hadjadj
Journal:  Diabetologia       Date:  2016-08-04       Impact factor: 10.122

Review 5.  Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential.

Authors:  Ines Batinić-Haberle; Júlio S Rebouças; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2010-09-15       Impact factor: 8.401

6.  Fcγ receptor deficiency attenuates diabetic nephropathy.

Authors:  Virginia Lopez-Parra; Beñat Mallavia; Oscar Lopez-Franco; Guadalupe Ortiz-Muñoz; Ainhoa Oguiza; Carlota Recio; Julia Blanco; Falk Nimmerjahn; Jesus Egido; Carmen Gomez-Guerrero
Journal:  J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 10.121

Review 7.  Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis?

Authors:  Wellington Santana da Silva Júnior; Amélio Fernando de Godoy-Matos; Luiz Guilherme Kraemer-Aguiar
Journal:  Biomed Res Int       Date:  2015-06-04       Impact factor: 3.411

8.  Inflammation in the pathogenesis of microvascular complications in diabetes.

Authors:  Dung V Nguyen; Lynn C Shaw; Maria B Grant
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-21       Impact factor: 5.555

9.  Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes.

Authors:  G N Fredrikson; D V Anand; D Hopkins; R Corder; R Alm; E Bengtsson; P K Shah; A Lahiri; J Nilsson
Journal:  Diabetologia       Date:  2009-05-12       Impact factor: 10.122

10.  Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women.

Authors:  Björn Fagerberg; Ulrica Prahl Gullberg; Ragnar Alm; Jan Nilsson; Gunilla Nordin Fredrikson
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.